By using in vivo tetracycline inducible silencing of CR-1 they also found that Cr-1 knockdown CSCs generates smaller tumor masses, with fewer CSCs and a dramatically reduced ability to generate metastasis compared to non-induced controls [69]. The gene discussed is CR1; the disease is neoplasm.